Immunic Therapeutics

NEWS

Multiple sclerosis damaged myelin or MS autoimmune disease with healthy nerve with exposed fibre with scarrred cell sheath loss as a 3D illustration.

Beyond BTK Inhibitors: Next Gen MS Treatments Could Transcend Symptom Management

While Bruton’s tyrosine kinase inhibitors are often hailed as the next big breakthrough in multiple sclerosis, Immunic Therapeutics and others are leveraging neuroprotective targets and remyelination to keep the disease at bay.

October 6, 2025

5 min read

Ben Hargreaves

IN THE PRESS

Press Releases

Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology

November 14, 2024

9 min read

Press Releases

Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

October 31, 2024

5 min read

Press Releases

Immunic to Participate in Industry, Scientific and Investor Conferences in November 2024

October 29, 2024

5 min read

Press Releases

Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis

October 23, 2024

10 min read

Press Releases

Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis

September 18, 2024

13 min read

Press Releases

Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome

September 4, 2024

10 min read

Press Releases

Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September 2024

August 28, 2024

8 min read

Press Releases

Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update

August 1, 2024

5 min read

Press Releases

Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec

July 24, 2024

7 min read

Pharm Country

Immunic to Participate in Industry and Scientific Conferences in June 2024

May 28, 2024

5 min read

JOBS